cinacalcet
cinacalcet: developed by 1 company · 1 FDA decision.
cinacalcet evidence translation
What we can confirm
1 FDA record
What it means
What to watch
Prepared research question
How could cinacalcet → RDY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
Development Pipeline (2)
| Company | Phase |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) | Approved |
| DR REDDYS LABORATORIES LTD (RDY) | Approved |
FDA Decisions1 records
Frequently asked questions
Who is developing cinacalcet?
cinacalcet is being developed by DR REDDYS LABORATORIES LTD.
What is cinacalcet's latest FDA decision?
The most recent tracked FDA decision for cinacalcet is Approval for 1 INDICATIONS AND USAGE Cinacalcet tablet is a positive modulator of the calcium sensing receptor indicated for: • Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. ( 1.1 ) Limitations of Use : Cinacalcet tablets are not indicated for use in patients with CKD who are not on dialysis • Hypercalcemia in adult patients with Parathyroid Carcinoma (PC). ( 1.2 ) • Hypercalcemia in adult patients with primary HPT for whom parathyroidectomy would be ind, dated September 18, 2020.